Cyclacel Pharmaceuticals, Inc. (CYCC)
USD 0.34
(-7.13%)
USD 0.34
(-7.13%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.11 Million | -20.82 Million | -18.54 Million | -7.93 Million | -9.44 Million | -6.7 Million |
| Net Income | -22.55 Million | -21.19 Million | -18.88 Million | -8.44 Million | -7.83 Million | -7.28 Million |
| Depreciation & Amortization | 31 Thousand | 32 Thousand | 43 Thousand | 20 Thousand | 20 Thousand | 29 Thousand |
| Deferred income taxes | -1.23 Million | 967 Thousand | 1.49 Million | -347 Thousand | - | - |
| Stock-based compensation | 1.47 Million | 1.5 Million | 1.15 Million | 430 Thousand | 466 Thousand | 331 Thousand |
| Change in working capital | 5 Million | -1.16 Million | -853 Thousand | 61 Thousand | -2.06 Million | 227 Thousand |
| Other non-cash items | 1.17 Million | -967 Thousand | -1.49 Million | 347 Thousand | -38 Thousand | -165 Thousand |
| Investing Cash Flow | -6000.00 | -7000.00 | -27 Thousand | -96 Thousand | 28 Thousand | -39 Thousand |
| Investments in PPE | -6000.00 | -7000.00 | -27 Thousand | -96 Thousand | -10 Thousand | -39 Thousand |
| Acquisitions | - | - | - | - | 38 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 38 Thousand | - |
| Financing Cash Flow | 848 Thousand | 2.99 Million | 21.73 Million | 29.5 Million | 3.84 Million | 429 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -201 Thousand | -201 Thousand | -201 Thousand | -201 Thousand | -201 Thousand | -201 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.04 Million | 3.19 Million | 21.93 Million | 29.7 Million | 4.04 Million | 630 Thousand |
| Other Financing Activities | 1.04 Million | 3.19 Million | 21.93 Million | 29.7 Million | 4.04 Million | 630 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 296 Thousand | 2.57 Million | 2.9 Million | 30 Thousand | -2.2 Million | 554 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.71 Million | -3.74 Million | -3.75 Million | 31 Thousand | 143 Thousand | -327 Thousand |
| Cash at beginning of period | 18.34 Million | 36.55 Million | 33.4 Million | 11.88 Million | 17.5 Million | 23.91 Million |
| Cash at end of period | 3.37 Million | 18.34 Million | 36.55 Million | 33.4 Million | 11.88 Million | 17.5 Million |
| Capital Expenditure | -6000.00 | -7000.00 | -27 Thousand | -96 Thousand | -10 Thousand | -39 Thousand |
| Effect of forex changes on cash | 303 Thousand | -378 Thousand | -17 Thousand | 47 Thousand | -48 Thousand | -95 Thousand |
| Net cash flow / Change in cash | -14.96 Million | -18.21 Million | 3.15 Million | 21.52 Million | -5.61 Million | -6.4 Million |
| Free Cash Flow | -16.11 Million | -20.83 Million | -18.56 Million | -8.03 Million | -9.45 Million | -6.74 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.25 Million | -2.94 Million | -22.55 Million | -5.27 Million | -6.03 Million | -5.44 Million |
| Depreciation & Amortization | 2000.00 | 2000.00 | 31 Thousand | 8000.00 | 7000.00 | 8000.00 |
| Deferred income taxes | - | - | -1.23 Million | -640.99 Thousand | 31 Thousand | - |
| Stock-based compensation | 189 Thousand | 203 Thousand | 1.47 Million | 322 Thousand | 391 Thousand | 359 Thousand |
| Change in working capital | -2000.00 | 2.27 Million | 5 Million | 1.04 Million | 1.55 Million | 3.79 Million |
| Other non-cash items | 1.35 Million | -63 Thousand | 1.17 Million | 627 Thousand | 9000.00 | -14 Thousand |
| Investing Cash Flow | - | - | -6000.00 | -4.21 Million | 4.21 Million | - |
| Investments in PPE | - | - | -6000.00 | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -4.21 Million | - | - |
| Financing Cash Flow | 6.28 Million | -79 Thousand | 848 Thousand | 999 Thousand | -50 Thousand | -51 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | -201 Thousand | -50 Thousand | -50 Thousand | -51 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 6.28 Million | -79 Thousand | 1.04 Million | 1.04 Million | - | - |
| Other Financing Activities | 6.28 Million | -79 Thousand | 1.04 Million | 1.04 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -1.17 Million | 254 Thousand | 296 Thousand | -303 Thousand | 1.53 Million | -733 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.17 Million | 2.02 Million | 4.71 Million | 1.34 Million | 20 Thousand | 4.52 Million |
| Cash at beginning of period | 2.79 Million | 3.37 Million | 18.34 Million | 5.94 Million | 10.16 Million | 11.43 Million |
| Cash at end of period | 6 Million | 2.79 Million | 3.37 Million | 3.37 Million | 5.94 Million | 10.16 Million |
| Capital Expenditure | - | - | -6000.00 | - | - | - |
| Effect of forex changes on cash | -3000.00 | -18 Thousand | 303 Thousand | 345 Thousand | -134 Thousand | 85 Thousand |
| Net cash flow / Change in cash | 3.2 Million | -580 Thousand | -14.96 Million | -2.56 Million | -4.22 Million | -1.27 Million |
| Free Cash Flow | -3.08 Million | -483 Thousand | -16.11 Million | -3.91 Million | -4.03 Million | -1.3 Million |
BLUMY
COMAN
4003
601336
6826
SY1